National Cancer Center Korea to Include E-cigarettes in Lung Cancer Screening from Next Year

Nov.08.2024
National Cancer Center Korea to Include E-cigarettes in Lung Cancer Screening from Next Year
The National Cancer Center Korea said lung cancer screening has over 80% sensitivity, but a 50% participation rate. E-cigarettes, especially heated tobacco products, will be included in future national screenings.

According to N.News on November 8th, the National Cancer Center in South Korea announced at a press conference during the International Academic Conference of the Lung Cancer Society (KALC) that the sensitivity of national lung cancer screening exceeds 80%, and the mortality rate of those who actually received screening is lower than those who did not.


Currently, the participation rate in screening is only 50%. According to regulations, the target population for screening should be individuals aged 54 to 74 with a 30-year history of smoking, and it is estimated that approximately 350,000 people meet this criteria each year. Professor Jin Lie of the organization pointed out that when the screening project was first launched, the participation rate was only 21%, but it increased to about 50% last year. The sensitivity reached around 80%, which is on par with other developed countries.


The organization stated that currently the target population for national lung cancer screening only considers traditional tobacco users, and does not include e-cigarette users. Researchers believe that further research on the relationship between e-cigarettes and lung cancer is needed.


Professor Jin Lie pointed out that just as it took a long time to establish the relationship between traditional tobacco and lung cancer, the impact of new forms of tobacco such as e-cigarettes will also need time for verification. It is expected that starting from next year, e-cigarettes, especially heated tobacco products, will be considered for inclusion in national screenings.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.